Literature DB >> 23942562

[Are the recommendations on tuberculosis screening still valid? Interferon gamma release assay (IGRA) and/or tuberculin skin test for diagnosis of latent tuberculosis infection (LTBI)].

D Ernst1, T Witte, R E Schmidt, D Meyer-Olson.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23942562     DOI： 10.1007/s00393-013-1169-y

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN： 0340-1855            Impact factor:   1.372


× No keyword cloud information.
  22 in total

1.  Influence of replacing tuberculin skin test with ex vivo interferon γ release assays on decision to administer prophylactic antituberculosis antibiotics before anti-TNF therapy.

Authors:  Xavier Mariette; Gabriel Baron; Florence Tubach; Frédéric Lioté; Bernard Combe; Corinne Miceli-Richard; René-Marc Flipo; Philippe Goupille; Matthieu Allez; Dominique Salmon; Dominique Emilie; Guislaine Carcelain; Philippe Ravaud
Journal:  Ann Rheum Dis       Date:  2012-01-17       Impact factor: 19.103

Review 2.  [Infectious complications of biologic therapy in patients with rheumatoid arthritis].

Authors:  D Meyer-Olson; K Hoeper; R E Schmidt
Journal:  Z Rheumatol       Date:  2010-12       Impact factor: 1.372

Review 3.  Interferon-γ release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis.

Authors:  R Diel; D Goletti; G Ferrara; G Bothamley; D Cirillo; B Kampmann; C Lange; M Losi; R Markova; G B Migliori; A Nienhaus; M Ruhwald; D Wagner; J P Zellweger; E Huitric; A Sandgren; D Manissero
Journal:  Eur Respir J       Date:  2010-10-28       Impact factor: 16.671

4.  Does anti-TNF therapy influence the performance of mycobacterium tuberculosis antigen-specific interferon-gamma assays? A French multicenter experience.

Authors:  E Del Tedesco; X Roblin; D Laharie; L Peyrin Biroulet
Journal:  Inflamm Bowel Dis       Date:  2011-01-06       Impact factor: 5.325

5.  You can't always get what you want, but if you try sometimes (with two tests--TST and IGRA--for tuberculosis) you get what you need.

Authors:  Kevin L Winthrop; Michael E Weinblatt; Charles L Daley
Journal:  Ann Rheum Dis       Date:  2012-09-12       Impact factor: 19.103

6.  Prednisolone treatment affects the performance of the QuantiFERON gold in-tube test and the tuberculin skin test in patients with autoimmune disorders screened for latent tuberculosis infection.

Authors:  Erika Bélard; Synne Semb; Morten Ruhwald; Anne Marie Werlinrud; Bolette Soborg; Frank Krieger Jensen; Henrik Thomsen; Annette Brylov; Merete Lund Hetland; Inge Nordgaard-Lassen; Pernille Ravn
Journal:  Inflamm Bowel Dis       Date:  2011-02-11       Impact factor: 5.325

7.  Long-term follow-up of patients with tuberculosis as a complication of tumour necrosis factor (TNF)-alpha antagonist therapy: safe re-initiation of TNF-alpha blockers after appropriate anti-tuberculous treatment.

Authors:  B Denis; A Lefort; R M Flipo; F Tubach; M Lemann; P Ravaud; D Salmon; X Mariette; O Lortholary
Journal:  Clin Microbiol Infect       Date:  2007-12-10       Impact factor: 8.067

8.  Risk of tuberculosis in patients treated with tumor necrosis factor antagonists due to incomplete prevention of reactivation of latent infection.

Authors:  Juan J Gómez-Reino; Loreto Carmona; Miguel Angel Descalzo
Journal:  Arthritis Rheum       Date:  2007-06-15

9.  Comparison of an interferon-gamma assay with tuberculin skin testing for detection of tuberculosis (TB) infection in patients with rheumatoid arthritis in a TB-endemic population.

Authors:  Dario Ponce de Leon; Eduardo Acevedo-Vasquez; Sergio Alvizuri; Cesar Gutierrez; Mariano Cucho; Jose Alfaro; Risto Perich; Alfredo Sanchez-Torres; Cesar Pastor; Cesar Sanchez-Schwartz; Mariela Medina; Rocio Gamboa; Manuel Ugarte
Journal:  J Rheumatol       Date:  2008-04-01       Impact factor: 4.666

10.  The BCG World Atlas: a database of global BCG vaccination policies and practices.

Authors:  Alice Zwerling; Marcel A Behr; Aman Verma; Timothy F Brewer; Dick Menzies; Madhukar Pai
Journal:  PLoS Med       Date:  2011-03-22       Impact factor: 11.069
View more
  1 in total

1.  [Secondary immunodeficiency in rheumatological diseases].

Authors:  D Ernst; R E Schmidt; T Witte
Journal:  Z Rheumatol       Date:  2013-09       Impact factor: 1.372
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.